Compare Smith & Nephew plc (SNN) vs Vanguard Value Index Fund ETF (VTV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs Vanguard Value Index Fund ETF — how do they compare? Smith & Nephew plc trades at $30.14 (market cap $12.38B), while Vanguard Value Index Fund ETF trades at $226.57. The key difference: Smith & Nephew plc pays a 2.66% dividend while Vanguard Value Index Fund ETF pays none, and Vanguard Value Index Fund ETF is trading nearer its 52-week high, Smith & Nephew plc nearer its low. Which is the better fit depends on your goals.
| SNN | VTV | |
|---|---|---|
Market Cap | $12.38B | — |
Sector | Health | — |
52-Week High | $38.70 | $226.29 |
52-Week Low | $28.73 | $180.25 |
Enterprise Value | $15.41B | — |
Dividend Yield | 2.66% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SNN trades at $30.11, up 0.33% today, with a bearish technical signal but improving fundamentals. Recent earnings show mixed results, beating in Q4 2025 and Q2 2026 but missing earlier quarters. Revenue growth has accelerated from $5.2B in 2022 to $6.16B in 2025, with net income margin expanding to 10.08%. The company maintains a dividend, with the next payment scheduled for November 2026. News highlights include product launches in robotics and wound care, though Q2 2026 revenue growth fell short of expectations.
Outlook is cautiously optimistic due to solid profitability and innovation, but risks include U.S. market softness and competitive pressures. Analysts largely recommend Hold, reflecting balanced growth potential against execution challenges. The stock's valuation at a P/E of 20.3 appears reasonable if earnings momentum continues, but investors should monitor operational execution closely.
Vanguard Value ETF (VTV) trades at $226.29, up 0.42% today, with a bullish technical signal from moving averages but neutral oscillators. Recent news highlights value stocks outperforming growth in 2026, with VTV up 22% year-to-date. The ETF focuses on large-cap U.S. value stocks, offering diversification with low technology exposure.
The outlook for VTV is positive as value investing gains traction amid AI sector volatility. Opportunities include steady dividends and resilience in market rotations. Risks involve reliance on economic cycles and potential underperformance if growth stocks rebound. Institutional activity shows mixed signals, with some firms increasing stakes while others reduce holdings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About Vanguard Value Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Value Index, a broadly diversified index predominantly made up of value stocks of large US companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VTV →
